Acquisition of JAK2, PTPN11, and RAS mutations during disease progression in primary myelodysplastic syndrome

被引：37
作者：
Chen, C-Y [1 ]
Lin, L-I
Tang, J-L
Tsay, W.
Chang, H-H
Yeh, Y-C
Huang, C-F
Chiou, R-J
Yao, M.
Ko, B-S
Chen, Y-C
Lin, K-H
Lin, D-T
Tien, H-F
机构：
[1] Natl Taiwan Univ, Coll Med, Dept Internal Med, Taipei 10018, Taiwan
[2] Natl Taiwan Univ, Coll Med, Dept Lab Med, Taipei 10018, Taiwan
[3] Natl Taiwan Univ, Coll Med, Dept Clin Sci & Med Biotechnol, Taipei 10018, Taiwan
[4] Natl Taiwan Univ, Coll Med, Dept Pediat, Taipei 10764, Taiwan
来源：
LEUKEMIA | 2006年 / 20卷 / 06期
关键词：
D O I：
10.1038/sj.leu.2404190
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1155 / 1158
页数：4
相关论文
共 9 条
  • [1] Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
    Baxter, EJ
    Scott, LM
    Campbell, PJ
    East, C
    Fourouclas, N
    Swanton, S
    Vassiliou, GS
    Bench, AJ
    Boyd, EM
    Curtin, N
    Scott, MA
    Erber, WN
    Green, AR
    [J]. LANCET, 2005, 365 (9464) : 1054 - 1061
  • [2] HUGUES L, 2005, HAEMATOLOGICA, V90, P853
  • [3] Mutations in PTPN11 are uncommon in adult myelodysplastic syndromes and acute myeloid leukaemia
    Johan, MF
    Bowen, DT
    Frew, ME
    Goodeve, AC
    Wilson, GA
    Peake, IR
    Reilly, JT
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2004, 124 (06) : 843 - 844
  • [4] The JAK2V617F activating mutation occurs in chronic myelomonocytic leukemia and acute myeloid leukemia, but not in acute lymphoblastic leukemia or chronic lymphocytic leukemia
    Levine, RL
    Loriaux, M
    Huntly, BJP
    Loh, ML
    Beran, M
    Stoffregen, E
    Berger, R
    Clark, JJ
    Willis, SG
    Nguyen, KT
    Flores, NJ
    Estey, E
    Gattermann, N
    Armstrong, S
    Look, AT
    Griffin, JD
    Bernard, OA
    Heinrich, MC
    Gilliland, DG
    Druker, B
    Deininger, MWN
    [J]. BLOOD, 2005, 106 (10) : 3377 - 3379
  • [5] RAS, FMS and p53 mutations and poor clinical outcome in myelodysplasias:: a 10-year follow-up
    Padua, RA
    Guinn, BA
    Al-Sabah, A
    Smith, M
    Taylor, C
    Pettersson, T
    Ridge, S
    Carter, G
    White, D
    Oscier, D
    Chevret, S
    West, R
    [J]. LEUKEMIA, 1998, 12 (06) : 887 - 892
  • [6] The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both "atypical" myeloproliferative disorders and myelodysplastic syndromes
    Steensma, DP
    Dewald, GW
    Lasho, TL
    Powell, HL
    McClure, RF
    Levine, RL
    Gilliland, DG
    Tefferi, A
    [J]. BLOOD, 2005, 106 (04) : 1207 - 1209
  • [7] SHP-2 and myeloid malignancies
    Tartaglia, M
    Niemeyer, CM
    Shannon, KM
    Loh, ML
    [J]. CURRENT OPINION IN HEMATOLOGY, 2004, 11 (01) : 44 - 50
  • [8] Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia
    Tartaglia, M
    Niemeyer, CM
    Fragale, A
    Song, XL
    Buechner, J
    Jung, A
    Hählen, K
    Hasle, H
    Licht, JD
    Gelb, BD
    [J]. NATURE GENETICS, 2003, 34 (02) : 148 - 150
  • [9] Molecular characterization of specific interactions between SHP-2 phosphatase and JAK tyrosine kinases
    Yin, TG
    Shen, R
    Feng, GS
    Yang, YC
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (02) : 1032 - 1037
1